Literature DB >> 18335019

Alternatives for heart transplantation?

J Brügemann1.   

Abstract

Year:  2008        PMID： 18335019      PMCID： PMC2245814          DOI： 10.1007/bf03086115

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  9 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Left ventricular assist device: a functional comparison with heart transplantation.

Authors:  R V Pruijsten; N de Jonge; J H Kirkels; C Klöpping; P A F M Doevendans; A Oosterom; H Kemperman; J R Lahpor
Journal:  Neth Heart J       Date:  2008-02       Impact factor: 2.380

3.  [The application of electric heart assist devices in 3 patients with end-stage heart failure as a bridge to transplantation].

Authors:  A P W M Maat; P J M J Vantrimpont; J A Bekkers; R J van Thiel; A H M M Balk; A J J C Bogers
Journal:  Ned Tijdschr Geneeskd       Date:  2002-02-23

4.  Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?

Authors:  N de Jonge; H Kirkels; J R Lahpor; C Klöpping; E J Hulzebos; A B de la Rivière; E O Robles de Medina
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

5.  Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure: Eight-year experience with the implantable HeartMate LVAS.

Authors:  J R Lahpor; N de Jonge; H A van Swieten; H Wesenhagen; C Klöpping; J H Geertman; A Oosterom; B Rodermans; J H Kirkels
Journal:  Neth Heart J       Date:  2002-06       Impact factor: 2.380

Review 6.  [Cardiac rehabilitation in patients with a congenital heart disease, an implantable cardioverter defibrillator or chronic heart failure].

Authors:  J Brügemann; K Postema; I C van Gelder; M H Oosterwijk; D J van Veldhuisen
Journal:  Ned Tijdschr Geneeskd       Date:  2004-09-11

7.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

8.  [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].

Authors:  J Brügemann; A T G de Jonge-Weber; M Rienstra; S A J van den Broek; F Zijlstra; D J van Veldhuisen
Journal:  Ned Tijdschr Geneeskd       Date:  2007-11-03

9.  Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Authors:  Katherine Lietz; James W Long; Abdallah G Kfoury; Mark S Slaughter; Marc A Silver; Carmelo A Milano; Joseph G Rogers; Yoshifumi Naka; Donna Mancini; Leslie W Miller
Journal:  Circulation       Date:  2007-07-16       Impact factor: 29.690
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.